Stubborn acne, fine hair thickening along the chin, periods that come and go without warning. These symptoms almost always lead a woman to the PCOS label. Yet there is another condition that can look strikingly similar, called NCAH. Telling the two apart matters, because the underlying cause is different and so is the treatment.

What NCAH is and why it mimics PCOS

NCAH stands for Non-Classical Adrenal Hyperplasia, the mild form of congenital adrenal hyperplasia. In most cases it is caused by a partial deficiency of an enzyme called 21-hydroxylase. It is a genetic condition inherited in an autosomal recessive pattern, meaning a person must inherit two affected copies of the gene, one from each parent.

When that enzyme underperforms, the adrenal glands produce too much androgen, the same hormone group that runs high in PCOS. The result is symptoms that can overlap heavily: acne, hirsutism (excess hair in a male pattern), infrequent periods, and sometimes difficulty conceiving.

The core difference lies in where the problem comes from. In PCOS, the excess androgen comes mainly from the ovaries and is influenced by insulin resistance. In NCAH, the main source is the adrenal glands sitting above the kidneys. Two different organs, two different mechanisms, even though the outward complaints look alike. That is why the 2023 international PCOS guideline (Monash, ESHRE, ASRM) lists NCAH as one of the conditions to rule out before a PCOS diagnosis is confirmed, in the same way we first exclude thyroid problems or high prolactin.

Classic versus non-classic: why “non-classic” is gentler

To understand NCAH, it helps to see the whole spectrum of congenital adrenal hyperplasia. The classic form is usually detected in infancy or early childhood because the enzyme deficiency is far more severe. It can disturb the body’s salt balance and sometimes changes the appearance of a baby girl’s genitals at birth. This form is serious and needs lifelong specialist care.

The non-classic form, the NCAH we are discussing here, is much gentler. The enzyme still works for the most part, so problems only surface later, often in the teenage years or early adulthood, and as mild to moderate androgen symptoms. This is exactly why NCAH is so often mistaken for PCOS: it disguises itself as the ordinary complaints that bring a woman to the clinic, not a dramatic condition obvious from birth. Understanding that NCAH sits at the mild end of the spectrum also helps ease worry. Getting an NCAH label does not mean you have the severe classic form.

A single morning blood test tells them apart

NCAH can be screened with one simple blood test, the level of 17-hydroxyprogesterone (17-OHP). This is an intermediate substance that builds up when 21-hydroxylase is insufficient, so its level tends to be high in NCAH but is usually normal in ordinary PCOS.

The timing of the sample matters a great deal and is often overlooked:

  • Take the blood early in the morning (ideally before 8 am), because 17-OHP peaks at that time.
  • Do it in the follicular phase, meaning within the first five days after your period starts. Drawn in the second half of the cycle, the level can read falsely high and mislead.

The rough interpretation goes like this. A very low basal 17-OHP makes NCAH unlikely, so this test is especially useful for confidently ruling out NCAH. A clearly elevated level strongly supports NCAH. The catch is that there is an ambiguous middle zone, and this is exactly where PCOS and NCAH results can overlap. That is why 17-OHP is treated as a screening test, not one that confirms the diagnosis on its own. For unclear middle values, the doctor may follow up with an ACTH stimulation test (sometimes called the cosyntropin or Synacthen test), where an injection is given and blood is retested after 60 minutes. This is the most accurate way to confirm or exclude NCAH when the baseline result is unclear, and it also helps decide whether a slightly raised level is truly meaningful. So if you are referred for a series of PCOS tests, it is worth asking whether 17-OHP is included. You can read more about the full blood panel in the PCOS blood tests guide.

One useful technical note: modern labs increasingly use a more precise measurement method (known as LC-MS/MS), and reference values can differ slightly between labs. This is another reason you should not interpret the number yourself. Ask the doctor to read the result against the relevant lab’s reference range.

Clues that make a doctor more suspicious of NCAH

No single symptom can tell NCAH and PCOS apart just by looking. Still, a few patterns make a doctor lean towards screening for NCAH:

  • Androgen signs that start very early, for example pubic or underarm hair appearing earlier than usual in childhood.
  • Hirsutism or acne that is more severe than expected.
  • A family history showing a similar picture. Certain ethnic backgrounds (for example Ashkenazi Jewish, Hispanic, Mediterranean, and Slavic ancestry) have higher carrier rates of the gene. For the Malaysian population, specific data is limited, so the decision to screen further leans on your clinical picture rather than ethnicity alone.
  • Difficulty conceiving alongside high androgen levels.

Even so, many adult women with NCAH simply present with a picture that looks like ordinary PCOS, with nothing dramatic. That is exactly why the 17-OHP test, not guesswork, is the deciding factor. The same idea applies to other distinctions in this section, such as Cushing syndrome versus PCOS: appearances can mislead, tests clarify.

Why this distinction genuinely matters

There are three practical reasons the correct label changes things.

First, NCAH is an inherited genetic condition. If you are a carrier and your partner is also a carrier, there is a chance a child could inherit a more classic and severe form. This information is useful for family planning, and genetic counselling is sometimes offered, especially when there is a concerning family history. This differs from the hereditary tendency in PCOS, which involves many genes rather than a single clean inheritance pattern.

Second, the treatment approach can differ. For PCOS, the focus is usually on lifestyle, weight management, and medicines like metformin or hormonal pills as needed. It is important to understand that many women with mild, untroubled NCAH actually do not need specific treatment at all. International guidelines do not recommend routine glucocorticoids for women with NCAH who have no troubling symptoms. For NCAH that does require treatment, doctors sometimes use low-dose glucocorticoids to calm the adrenal androgen output, a strategy that does not apply to ordinary PCOS. This decision can only be made by an endocrinologist or gynaecologist, because it involves weighing the benefits against the side effects of long-term steroids.

Third, even though NCAH explains the androgen symptoms, it does not automatically cancel metabolic risk. Both conditions deserve good long-term monitoring, including awareness of heart health, blood pressure, and blood sugar over time.

Fertility and pregnancy with NCAH

The biggest worry for many women is fertility. For most women with NCAH, reported pregnancy rates are close to normal, and not everyone needs treatment to conceive. Some women conceive naturally without any intervention.

For those who do face difficulty conceiving or have had recurrent miscarriage, a doctor may consider a particular type of glucocorticoid that does not cross the placenta, under specialist supervision. This differs from the PCOS fertility approach, which more often uses ovulation-stimulating medicines. If you are planning a pregnancy and have a diagnosis or suspicion of NCAH, talk to a specialist early, because some decisions (including carrier screening for a partner) are better planned before pregnancy than after.

Practical steps for Malaysian women

You do not have to carry this diagnosis on your own. In Malaysia, a sensible path starts at a Klinik Kesihatan KKM, which charges around RM1 per visit for citizens and includes basic investigations, with follow-up usually around RM5. The medical officer can assess your symptoms and refer you to a hospital gynaecology or endocrine clinic if the 17-OHP or clinical picture raises questions. Specialised tests like ACTH stimulation are usually done at a hospital clinic after referral. Private clinics offer faster access but costs vary, so ask for an estimate first.

A few useful things to bring to your appointment:

  • A list of your symptoms and when they began, especially if androgen signs appeared in childhood.
  • Details of your menstrual cycle, so the test can be scheduled in the right phase (the first five days after your period starts).
  • Family history related to hormonal problems, fertility, or androgen excess.

Questions you can ask the doctor to make the discussion clearer:

  • “Has my 17-OHP level been tested, and was it taken in the morning and in the right phase?”
  • “If the value is in the middle zone, do I need an ACTH stimulation test?”
  • “If this is NCAH, do I really need treatment now, or is monitoring enough?”
  • “What does it mean for my family planning?”

If you have just received any diagnosis and feel overwhelmed, the newly diagnosed PCOS guide helps you organise your first steps calmly. For the foundational overview, start with the what is PCOS page. Most importantly, do not rush to conclusions from a single test value on your own. Let the doctor interpret it in the full context, because that is what separates guesswork from a real diagnosis.

When to see a doctor

See a doctor if your androgen symptoms (severe acne, excess hair, very infrequent periods) worsen quickly, if these signs have been present since childhood, or if you face difficulty conceiving alongside these complaints. Seek prompt assessment if there are voice changes, a sudden increase in muscle bulk, or clitoral enlargement, as these need quicker investigation. The level of evidence for the 17-OHP test as a screen is strong and widely accepted, so asking for it is a reasonable request.